Viking Therapeutics, Inc. ($VKTX)
ZANTE GREG โ Chief Financial Officer
Shares
21,217
Price
$33.47
Total Value
$710,141.48
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | ZANTE GREG |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Jul 29, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock, par value $0.00001 per share |
| Direct/Indirect | Direct |
| Filing Date | Jul 30, 2026 |
| Shares Sold | 21,217 |
| Price per Share | $33.47 |
| Total Value | $710,141.48 |
| Shares Owned After | 212,204 |
| Derivative | No |
| Accession Number | 0001193125-26-324447 |
| Document | View SEC Filing |